Correlia Biosystems, Inc.
Biotechnology company · Berkeley, California, United States
Correlia Biosystems, Inc. is a biotechnology company headquartered in Berkeley, California, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $673,898 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $1.3 million sold in a notice filed in 2023.
Correlia Biosystems at a glance
What does Correlia Biosystems do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $673,898 in total (2014 to 2016). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.3 million sold (2023).
Frequently asked questions about Correlia Biosystems
Where is Correlia Biosystems headquartered?
Correlia Biosystems, Inc. is headquartered in Berkeley, California, United States.
What does Correlia Biosystems do?
Correlia Biosystems, Inc. is a biotechnology company.
Similar companies
- Caribou Biosciences, Inc.Berkeley, California, United States
- Newomics Inc.Berkeley, California, United States
- Synvivia, Inc.Berkeley, California, United States
- Actym Therapeutics, Inc.Berkeley, California, United States
- Yourchoice Therapeutics IncBerkeley, California, United States
- Valitor, Inc.Berkeley, California, United States
- Organos, Inc.Berkeley, California, United States
- Indee. Inc.Berkeley, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences